253 related articles for article (PubMed ID: 29039056)
1. Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes.
Greenbaum C; Lord S; VanBuecken D
Curr Diab Rep; 2017 Oct; 17(11):119. PubMed ID: 29039056
[TBL] [Abstract][Full Text] [Related]
2. Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice.
Greenbaum C; VanBuecken D; Lord S
Drugs; 2019 Jan; 79(1):43-61. PubMed ID: 30612319
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success.
Rekers NV; von Herrath MG; Wesley JD
Clin Immunol; 2015 Nov; 161(1):37-43. PubMed ID: 26122172
[TBL] [Abstract][Full Text] [Related]
4. Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes.
Lord S; Greenbaum CJ
F1000Res; 2020; 9():. PubMed ID: 32789003
[TBL] [Abstract][Full Text] [Related]
5. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.
Schneider DA; Kretowicz AM; von Herrath MG
Diabetes Obes Metab; 2013 Jul; 15(7):581-92. PubMed ID: 23194064
[TBL] [Abstract][Full Text] [Related]
6. Predicting type 1 diabetes using biomarkers.
Bonifacio E
Diabetes Care; 2015 Jun; 38(6):989-96. PubMed ID: 25998291
[TBL] [Abstract][Full Text] [Related]
7. Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes.
Creusot RJ; Battaglia M; Roncarolo MG; Fathman CG
Stem Cells; 2016 Apr; 34(4):809-19. PubMed ID: 26840009
[TBL] [Abstract][Full Text] [Related]
8. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
10. Type 1 Diabetes: Current Perspectives.
Kozhakhmetova A; Gillespie KM
Methods Mol Biol; 2016; 1433():1-9. PubMed ID: 26659804
[TBL] [Abstract][Full Text] [Related]
11. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for immune intervention trials in type 1 diabetes.
Mallone R; Roep BO
Clin Immunol; 2013 Dec; 149(3):286-96. PubMed ID: 23510725
[TBL] [Abstract][Full Text] [Related]
13. Antigen-Specific Peptide Immunotherapy for Type 1 Diabetes: Proof of Safety, Hope for Efficacy.
Coppieters K; von Herrath M
Cell Metab; 2017 Oct; 26(4):595-597. PubMed ID: 28978425
[TBL] [Abstract][Full Text] [Related]
14. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
15. Early Intervention by Family Physicians to Delay Type 1 Diabetes.
Edelman S
J Fam Pract; 2023 Jul; 72(6 Suppl):S19-S24. PubMed ID: 37549417
[TBL] [Abstract][Full Text] [Related]
16. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
17. What defines disease in an age of genetics and biomarkers?
Gottlieb PA
Curr Opin Endocrinol Diabetes Obes; 2015 Aug; 22(4):296-9. PubMed ID: 26087344
[TBL] [Abstract][Full Text] [Related]
18. Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes.
Thomas R; Carballido JM; Wesley JD; Ahmed ST
Front Immunol; 2021; 12():730414. PubMed ID: 34421931
[TBL] [Abstract][Full Text] [Related]
19. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
[TBL] [Abstract][Full Text] [Related]
20. Role of humoral beta-cell autoimmunity in type 1 diabetes.
Knip M; Siljander H; Ilonen J; Simell O; Veijola R
Pediatr Diabetes; 2016 Jul; 17 Suppl 22():17-24. PubMed ID: 27411432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
